Cart
0
£0.00
Hannah brings her expertise in molecular biology, renal medicine, and gene therapies into her current leadership role at NHS Wales JCC. Her keynote will open the Trends House by framing how real-world data and patient-reported outcomes are transforming commissioning decisions and the delivery of ATMPs in Wales.